2016
DOI: 10.1016/j.nano.2016.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
32
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 48 publications
(34 citation statements)
references
References 50 publications
2
32
0
Order By: Relevance
“…However, in the same study no significant difference in siRNA delivery was observed between PEGylated-CD.siRNA and CD.siRNA [116]. Evans et al [117] designed a CD.siRNA-DSPE-PEG 5000 -folate nanoparticle to determine the gene silencing ability in prostate cancer cell lines. Prostate-specific membrane antigen (PSMA) is upregulated in prostate cancer, and its expression increases as the cancer metastasizes.…”
Section: Polymer-based Nanomaterials For Gene Deliverymentioning
confidence: 99%
See 3 more Smart Citations
“…However, in the same study no significant difference in siRNA delivery was observed between PEGylated-CD.siRNA and CD.siRNA [116]. Evans et al [117] designed a CD.siRNA-DSPE-PEG 5000 -folate nanoparticle to determine the gene silencing ability in prostate cancer cell lines. Prostate-specific membrane antigen (PSMA) is upregulated in prostate cancer, and its expression increases as the cancer metastasizes.…”
Section: Polymer-based Nanomaterials For Gene Deliverymentioning
confidence: 99%
“…Incorporation of DSPE-PEG5000 was utilized to reduce the overall cationic charge of the particle to limit clearance by RES system. Three different formulations of cyclodextrin complexed with siRNA were used (Figure 6): CCD (cationic amphiphilic cyclodextrin /siRNA), CD-M (Cyclodextrin/siRNA-DSPE-PEG 5000 -methyl) and CD-F (Cyclodextrin/siRNA-DSPE-PEG 5000 -folate), and their gene delivery and targeting uptake potentials were assessed in PSMA-positive and PSMA-negative cells [117]. The CD-F formulation resulted in increased targeted uptake and gene delivery potential in PSMA-positive cells (VCaP and LNCaP) compared to CD-M.…”
Section: Polymer-based Nanomaterials For Gene Deliverymentioning
confidence: 99%
See 2 more Smart Citations
“…[11][12][13] Accordingly, it can be used to down-regulate the expression of drug resistance proteins and reverse MDR in cancer cells. 18 Natural cationic polymer chitosan (CS) has been widely used in gene delivery vectors because of its good biocompatibility, biodegradability and low toxicity, amongst other advantages. [14][15][16][17] Therefore, it is necessary to identify a safe and effective siRNA delivery vector to effectively delivery siRNA into tumor cells.…”
mentioning
confidence: 99%